Drug-Drug Interaction Study With Aricept® (Donepezil)

Completed · Phase 1

Conditions studied: Alzheimer Disease

In brief

The purpose of this study is to find out if the plasma concentration of donepezil is changed when BMS-708163 is administered at the same time

Key facts

Study ID

NCT01042314

Run by

Bristol-Myers Squibb

People needed

18

Starts

2010-01-01

Expected to finish

2010-04-01

Last updated by the study team

2011-01-25

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Healthy men and postmenopausal women

You may not qualify if…

• Medical History and Concurrent Diseases
• Gastrointestinal disease
• Gastrointestinal bleeding disorders
• History of peptic ulcer disease
• History of cholecystectomy
• History of seizure disorder
• History of asthma
• History of Chronic Obstructive Pulmonary Disease
• History of cardiac conduction abnormalities, including but not limited to "sick sinus syndrome" and those with unexplained syncopal episodes
• Inability to tolerate oral medication
• Inability to be venipunctured and/or tolerate venous access

Where it is running

• Parexel International - Baltimore Epcu — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.